HMOX1 and lip and oral cavity carcinoma: In summary, we indicated that the curcumin analog FLLL32 can suppress oral cancer cell viability—as well as induce G2/M cell-cycle arrest and caspase-dependent apoptosis—by activating the p38–HO-1 axis.